We are live on ! Find out more
NUS icon

Nu Skin

212 hedge funds and large institutions have $814M invested in Nu Skin in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 82 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.7% more ownership

Funds ownership: 82.1%84.8% (+2.7%)

0% more funds holding

Funds holding: 212212 (0)

0% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 32

6% less capital invested

Capital invested by funds: $870M → $814M (-$56.5M)

17% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 82

53% less call options, than puts

Call options by funds: $1.94M | Put options by funds: $4.17M

Holders
212
Holders Change
Holders Change %
0%
% of All Funds
3.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
68
Reduced
82
Closed
32
Calls
$1.94M
Puts
$4.17M
Net Calls
-$2.22M
Net Calls Change
-$1.98M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$165M +$8.54M +462,531 +6%
Vanguard Group
2
Vanguard Group
Pennsylvania
$121M -$373K -20,224 -0.3%
State Street
3
State Street
Massachusetts
$55.8M -$2.43M -131,676 -4%
Invesco
4
Invesco
Georgia
$55.5M +$21.5M +1,162,785 +69%
Morgan Stanley
5
Morgan Stanley
New York
$37.9M +$15.6M +845,858 +77%
Renaissance Technologies
6
Renaissance Technologies
New York
$37.5M -$1.21M -65,600 -3%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$27M -$6.38M -345,859 -20%
Charles Schwab
8
Charles Schwab
California
$22.5M +$3.2M +173,193 +18%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$20.7M -$509K -27,607 -3%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$16.2M +$1.28M +69,108 +9%
ACB
11
Aristotle Capital Boston
Massachusetts
$15.5M +$376K +20,399 +3%
Northern Trust
12
Northern Trust
Illinois
$10.7M -$63K -3,413 -0.6%
Citadel Advisors
13
Citadel Advisors
Florida
$10.3M -$7.62M -412,995 -44%
Voloridge Investment Management
14
Voloridge Investment Management
Florida
$9.62M +$1.25M +67,492 +16%
Norges Bank
15
Norges Bank
Norway
$8.93M -$1.65M -89,526 -16%
Victory Capital Management
16
Victory Capital Management
Texas
$8.91M -$36K -1,952 -0.4%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$8.68M +$1.29M +69,800 +19%
ProShare Advisors
18
ProShare Advisors
Maryland
$8.5M +$1.8M +97,541 +29%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$8.45M +$2.25M +122,059 +39%
American Century Companies
20
American Century Companies
Missouri
$7.03M -$366K -19,826 -5%
Two Sigma Investments
21
Two Sigma Investments
New York
$6.66M -$7.25K -393 -0.1%
Federated Hermes
22
Federated Hermes
Pennsylvania
$6.42M +$6.08M +329,700 +29,649%
Hotchkis & Wiley Capital Management
23
Hotchkis & Wiley Capital Management
California
$5.83M +$1.32M +71,790 +31%
Millennium Management
24
Millennium Management
New York
$5.37M -$8.48M -459,447 -62%
Principal Financial Group
25
Principal Financial Group
Iowa
$5M -$214K -11,572 -4%

NUS Hedge Fund Activity: Q4 2023 in Review

212 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Nu Skin (NUS) for Q4 2023, worth a combined $814M — down 6.5% from $870M a quarter earlier.

Fund positioning in NUS was balanced in Q4 2023: 32 funds opened new positions, 32 closed out, 68 added to existing stakes and 82 trimmed.

The largest buyer was Invesco, adding an estimated $21.5M. The largest seller was Marshall Wace, cutting an estimated $16.4M.

  • 212 institutional investors held Nu Skin (NUS) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $814M of Nu Skin stock for Q4 2023, down 6.5% quarter-over-quarter.
  • 32 funds opened new Nu Skin positions in Q4 2023 and 32 closed out, a net change of 0 holders.
  • The largest Nu Skin buyer in Q4 2023 was Invesco, an estimated $21.5M added.
  • The largest Nu Skin seller in Q4 2023 was Marshall Wace, an estimated $16.4M sold.

Based on aggregated 13F filings for Q4 2023.